NCT05202860View on ClinicalTrials.gov

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

June 19, 2024

Study Completion Date

June 19, 2034

Conditions
Actinic KeratosesBasal Cell CarcinomaSquamous Cell Carcinoma
Interventions
BIOLOGICAL

HPV Vaccine

(Gardasil 9 human papilloma vaccine)

BIOLOGICAL

PLACEBO vaccine

Isotonic saltwater sham vaccine

Trial Locations (1)

2400

Department of Dermatology, Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Merete Haedersdal

OTHER